Skip to main content
Premium Trial:

Request an Annual Quote

Ovation Life Sciences Raises $1.5M

NEW YORK (GenomeWeb) – Scientific data management firm Ovation Life Sciences announced today that it has received $1.5 million in funding from a group of new and existing investors.

Participants in the financing included StageDotO and Longfellow Ventures.

Ovation's main products are a lab service for the tracking of samples, workflows, and processes, and a research service for facilitating collaboration and data sharing between separate teams. The company intends to use the money to continue development of its next-generation data layer-as-a-service platforms.

The company also announced today that it has signed an agreement under which its research service will be used by members of the International Genetics and Translational Research in Transplantation Network (iGeneTrain). Specific terms of the deal were not disclosed. 

"The premise behind iGeneTrain is that better sharing and understanding of the global data on transplants and their genetic factors will improve outcomes," Brendan Keating, iGeneTrain Cofounder and University of Pennsylvania researcher, said in a statement. "Our collaboration with Ovation will significantly improve and accelerate that process."

The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.